John B Watkins, Sean D Sullivan. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDecision MakingDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/economicsEvidence-Based MedicineHumansHypoglycemic Agents/economicsHypoglycemic Agents/therapeutic useInsurance Coverage/economicsInsurance Coverage/organization & administrationInsurance, Pharmaceutical Services/economicsManaged Care Programs/economicsPharmaceutical Preparations/economics
Substances: See more » Hypoglycemic AgentsPharmaceutical Preparations
Year: 2009 PMID: 19236133 DOI: 10.18553/jmcp.2009.15.2.167
Source DB: PubMed Journal: J Manag Care Pharm ISSN: 1083-4087